Table 2 Overview of the genetically solved cohort.
Solved cases (n) | Solved cohort (%) | ||
|---|---|---|---|
Sex | Female | 904 | 44.40 |
Male | 1132 | 55.60 | |
Genotyping method | NGS panel-based analysis | 1181 | 58.01 |
APEX-based microarray | 55 | 2.70 | |
Single-gene testing | 587 | 28.83 | |
Familiar variant analysis | 201 | 9.87 | |
Other (array CGH, MLPA) | 12 | 0.59 | |
Zygosity | Homozygous | 455 ‡ | 22.35 |
Compound heterozygous | 1002 ‡ | 49.21 | |
Hemizygous | 238 | 11.69 | |
Heterozygous | 283 | 13.90 | |
Heterozygous symptomatic carriers of X-linked forms | 16 | 0.79 | |
Mitochondrial inheritance | 42 | 2.06 |
Number of variants | Fraction of identified variants (%) | ||
|---|---|---|---|
Functional category | Missense | 1808* | 50.75 |
Nonsense | 609 | 17.10 | |
Frameshift | 542 | 15.22 | |
Splicing site variant | 430 | 12.07 | |
Other (CNV, deep-intronic, small in/del, start/stop-loss) | 173 | 4.86 |